ImmuPharma (LON:IMM) Stock Crosses Below 200-Day Moving Average of $5.94

ImmuPharma plc (LON:IMMGet Rating)’s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 5.94 ($0.07) and traded as low as GBX 4.50 ($0.05). ImmuPharma shares last traded at GBX 4.82 ($0.06), with a volume of 204,449 shares traded.

ImmuPharma Trading Down 31.0 %

The company has a current ratio of 2.11, a quick ratio of 1.76 and a debt-to-equity ratio of 0.02. The company has a 50-day simple moving average of GBX 5.85 and a 200 day simple moving average of GBX 5.94. The firm has a market cap of £9.85 million and a PE ratio of -0.91.

About ImmuPharma

(Get Rating)

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.

Recommended Stories

Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.